There are claims, ranging from anecdotal reports to experimental research, that cannabis and its derivative compounds have medicinal use for diabetes.
Statin Therapy with Type 2 Diabetes & Nephropathy
In patients with type 2 diabetes complicated by nephropathy, what is the real life effect of statin therapy on cardiovascular disease prevention?
Insulin 2016: FDA News
A roundup of insulin-related FDA news includes approved combination medications, the latest devices, and CT imaging recommendations for insulin pumps.
Type 2 Diabetes and Insulin: Physician Reluctance
Do you hesitate to initiate insulin therapy in type 2 diabetes patients? To understand barriers, researchers conducted a cross-sectional survey.
Five Fallacies (and Facts) about Diabetes
With the holidays upon us, this month’s topic is a timely one – diet/physical activity misconceptions you may hear from patients and their families.
Beverage Choice: Impact on Prediabetes, Weight
Two studies examined the effects of sugar-sweetened beverages on prediabetes and insulin resistance and of low-calorie beverages on weight loss.
SGLT2 Inhibitors 2016: Year-End News Roundup
SGLT2 inhibitors made diabetes headlines this year by gaining FDA approval for cardiovascular indication. We highlight this news and more for 2016.
Cardiovascular Effect of an SGLT2i: Case Study
A 68-year-old man with long-standing hypertension, ischemic heart disease, obesity, T2DM, & rheumatoid arthritis was treated with an SGLT2 inhibitor.
Chocolate and Type 2 Diabetes: a Healthy Habit?
Compounds in cocoa and chocolate have known cardiovascular benefits. Could habitual chocolate intake lower the risk of type 2 diabetes as well?
CV Risks and Diabetes: Puerto Rican Population
Dr. Bobby Lazzara discusses a study looking at certain demographics and cardiovascular complications in a diabetic patient population in Puerto Rico.
Safety of Closed-Loop Insulin Delivery System
Dr. Bobby Lazzara reviews the safety of a hybrid closed-loop insulin delivery system for patients with type 1 diabetes in a real-world setting.
AHA 2016: Obesity Paradox in Heart Failure
Does the obesity paradox exist in heart failure? What roles do ejection fraction and type 2 diabetes & acute decompensated heart failure play?
By clicking Accept, you agree to become a member of the UBM Medica Community.